EE516 Budget-Impact Model of Adalimumab-Biosimilar Sandoz in the Management of Autoimmune Diseases in the Middle East
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.758
https://www.valueinhealthjournal.com/article/S1098-3015(22)02962-X/fulltext
Section Title :
Section Order :
10300
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02962-X&doi=10.1016/j.jval.2022.09.758